Experiments In Non-human Primates Research Articles

Potential of human twin embryos generated by embryo splitting in assisted reproduction and research.

Embryo splitting or twinning has been widely used in veterinary medicine over 20 years to generate monozygotic twins with desirable genetic characteristics. The first human embryo splitting, reported in 1993, triggered fierce ethical debate on human embryo cloning. Since Dolly the sheep was born in 1997, the international community has acknowledged the complexity of the moral arguments related to this research and has expressed concerns about the potential for reproductive cloning in humans. A number of countries have formulated bans either through laws, decrees or official statements. However, in general, these laws specifically define cloning as an embryo that is generated via nuclear transfer (NT) and do not mention embryo splitting. Only the UK includes under cloning both embryo splitting and NT in the same legislation. On the contrary, the Ethics Committee of the American Society for Reproductive Medicine does not have a major ethical objection to transferring two or more artificially created embryos with the same genome with the aim of producing a single pregnancy, stating that 'since embryo splitting has the potential to improve the efficacy of IVF treatments for infertility, research to investigate the technique is ethically acceptable'. Embryo splitting has been introduced successfully to the veterinary medicine several decades ago and today is a part of standard practice. We present here an overview of embryo splitting experiments in humans and non-human primates and discuss the potential of this technology in assisted reproduction and research. A comprehensive literature search was carried out using PUBMED and Google Scholar databases to identify studies on embryo splitting in humans and non-human primates. 'Embryo splitting' and 'embryo twinning' were used as the keywords, alone or in combination with other search phrases relevant to the topics of biology of preimplantation embryos. A very limited number of studies have been conducted in humans and non-human primates. The published material, especially the studies with human embryos, is controversial. Some reports suggest that twinning technology will find clinical use in reproductive medicine in the future, whereas others conclude the opposite that human twin embryos created in vitro are unsuitable not only for clinical, but also for research, purposes. The blastomere biopsy technique of embryo splitting seems to be unsuitable for either clinical or research purposes; however, embryo bisection, a preferable method of cloning in veterinary medicine, has not yet been tested on human embryos.

Anticonvulsant discovery through animal models of status epilepticus induced by organophosphorus nerve agents and pesticides.

Organophosphorus pesticides (OPs) and nerve agents (NAs) are highly toxic chemicals that pose a significant threat to human health worldwide. These compounds induce status epilepticus (SE) by irreversibly blocking the ability of acetylcholinesterase to break down acetylcholine at neural synapses. Animal models of organophosphate-induced SE are a crucial resource for identifying new anticonvulsant therapies. Here, we describe the development of various animal models of SE induced by NA or OP exposure. Experiments in nonhuman primates, rats, mice, and guinea pigs have helped to identify novel therapeutic targets in the central nervous system, with particular success at modulating GABAergic and glutamatergic receptors. The anticonvulsants identified by NA- and OP-induced SE models are well poised for fast advancement into clinical development, and their potential utility in the broader field of epilepsy should make them all the more attractive for commercial pursuit.

Reward and decision processes in the brains of humans and nonhuman primates

Choice behavior requires weighing multiple decision variables, such as utility, uncertainty, delay, or effort, that combine to define a subjective value for each considered option or course of action. This capacity is based on prior learning about potential rewards (and punishments) that result from prior actions. When made in a social context, decisions can involve strategic thinking about the intentions of others and about the impact of others' behavior on one's own outcome. Valuation is also influenced by different emotions that serve to adaptively regulate our choices in order to, for example, stay away from excessively risky gambles, prevent future regrets, or avoid personal rejection or conflicts. Drawing on economic theory and on advances in the study of neuronal mechanisms, we review relevant recent experiments in nonhuman primates and clinical observations made in neurologically impaired patients suffering from impaired decision-making capacities.

The Ethics of Infection Challenges in Primates.

In the midst of the recent Ebola outbreak, scientific developments involving infection challenge experiments on nonhuman primates (NHPs) sparked hope that successful treatments and vaccines may soon become available. Yet these studies pose a stark ethical quandary. On the one hand, they represent an important step in developing novel therapies and vaccines for Ebola and the Marburg virus, with the potential to save thousands of human lives and to protect whole communities from devastation; on the other hand, they intentionally expose sophisticated animals to severe suffering and a high risk of death. Other studies that infect NHPs with a lethal disease in order to test interventions that may prove beneficial for humans pose the same ethical difficulty. Some advocates have argued that all research on primates should be phased out, and ethicists have questioned whether a moral justification of primate research is possible. A 2010 European Union directive banned virtually all research on great apes, and 2013 guidelines from the National Institutes of Health (NIH), based upon recommendations in an influential 2011 Institute of Medicine (IOM) report, eliminated most biomedical research with chimpanzees in the United States. But studies involving other NHPs face no comparable restrictions. Should research on NHPs other than great apes be subject to tighter restrictions than it currently is? In this article, we explore this general question in the context of one particular type of biomedical research: infection challenge studies. We advocate a presumptive prohibition on infection challenge experiments in NHPs, but we also argue that exceptions to this prohibition are permissible, subject to strict substantive and procedural safeguards, when necessary to avert substantial loss of human life or severe morbidity for a substantial number of people.

Non-human primates in neuroscience research: The case against its scientific necessity.

Public opposition to non-human primate (NHP) experiments is significant, yet those who defend them cite minimal harm to NHPs and substantial human benefit. Here we review these claims of benefit, specifically in neuroscience, and show that: a) there is a default assumption of their human relevance and benefit, rather than robust evidence; b) their human relevance and essential contribution and necessity are wholly overstated; c) the contribution and capacity of non-animal investigative methods are greatly understated; and d) confounding issues, such as species differences and the effects of stress and anaesthesia, are usually overlooked. This is the case in NHP research generally, but here we specifically focus on the development and interpretation of functional magnetic resonance imaging (fMRI), deep brain stimulation (DBS), the understanding of neural oscillations and memory, and investigation of the neural control of movement and of vision/binocular rivalry. The increasing power of human-specific methods, including advances in fMRI and invasive techniques such as electrocorticography and single-unit recordings, is discussed. These methods serve to render NHP approaches redundant. We conclude that the defence of NHP use is groundless, and that neuroscience would be more relevant and successful for humans, if it were conducted with a direct human focus. We have confidence in opposing NHP neuroscience, both on scientific as well as on ethical grounds.

Design of an implantable artificial dural window for chronic two-photon optical imaging in non-human primates.

Optical functional imaging methods such as calcium imaging have become a powerful tool for investigating neural activity in-vivo. Here, we present a design for a titanium implantable chamber with transparent silicone artificial dura which enables two-photon calcium imaging in non-human primates. This chamber accommodates imaging with high numerical aperture multiphoton objective lenses, and remains sealed, protecting the brain from the surrounding environment. In addition, we describe a tunable tissue stabilization system to apply gentle mechanical pressure to stabilize tissue during imaging. Our results suggest that two-photon calcium imaging may soon facilitate a new class of circuit and systems neuroscience experiments in non-human primates.

Proton Resonance Frequency Chemical Shift Thermometry: Experimental Design and Validation toward High-Resolution Noninvasive Temperature Monitoring and In Vivo Experience in a Nonhuman Primate Model of Acute Ischemic Stroke

Applications for noninvasive biologic temperature monitoring are widespread in biomedicine and of particular interest in the context of brain temperature regulation, where traditionally costly and invasive monitoring schemes limit their applicability in many settings. Brain thermal regulation, therefore, remains controversial, motivating the development of noninvasive approaches such as temperature-sensitive nuclear MR phenomena. The purpose of this work was to compare the utility of competing approaches to MR thermometry by using proton resonance frequency chemical shift. We tested 3 methodologies, hypothesizing the feasibility of a fast and accurate approach to chemical shift thermometry, in a phantom study at 3T. A conventional, paired approach (difference [DIFF]-1), an accelerated single-scan approach (DIFF-2), and a new, further accelerated strategy (DIFF-3) were tested. Phantom temperatures were modulated during real-time fiber optic temperature monitoring, with MR thermometry derived simultaneously from temperature-sensitive changes in the water proton chemical shift (∼0.01 ppm/°C). MR thermometry was subsequently performed in a series of in vivo nonhuman primate experiments under physiologic and ischemic conditions, testing its reproducibility and overall performance. Chemical shift thermometry demonstrated excellent agreement with phantom temperatures for all 3 approaches (DIFF-1: linear regression R(2) = 0.994; P < .001; acquisition time = 4 minutes 40 seconds; DIFF-2: R(2) = 0.996; P < .001; acquisition time = 4 minutes; DIFF-3: R(2) = 0.998; P < .001; acquisition time = 40 seconds). These findings confirm the comparability in performance of 3 competing approaches to MR thermometry and present in vivo applications under physiologic and ischemic conditions in a primate stroke model.

The protein DIIIC‐2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV‐2

Previously, we reported the ability of the chimeric protein DIIIC-2 (domain III of the dengue envelope protein fused to the capsid protein of dengue-2 virus), to induce immunity and protection in mice, when it is highly aggregated with a non-defined oligodeoxynucleotide (ODN) and adjuvanted in alum. In this work, three different defined ODNs were studied as aggregating agents. Our results suggest that the nature of the ODN influences the capacity of protein DIIIC-2 to activate cell-mediated immunity in mice. Consequently, the ODN 39M was selected to perform further experiments in mice and nonhuman primates. Mice receiving the preparation 39M-DIIIC-2 were solidly protected against dengue virus (DENV) challenge. Moreover, monkeys immunized with the same preparation developed neutralizing antibodies, as measured by four different neutralization tests varying the virus strains and the cell lines used. Two of the immunized monkeys were completely protected against challenge, whereas the third animal had a single day of low-titer viremia. This is the first work describing the induction of short-term protection in monkeys by a formulation that is suitable for human use combining a recombinant protein from DENV with alum.

Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo.

Over the past 5 years, a new generation of highly potent and broadly neutralizing HIV-1 antibodies has been identified. These antibodies can protect against lentiviral infection in nonhuman primates (NHPs), suggesting that passive antibody transfer would prevent HIV-1 transmission in humans. To increase the protective efficacy of such monoclonal antibodies, we employed next-generation sequencing, computational bioinformatics, and structure-guided design to enhance the neutralization potency and breadth of VRC01, an antibody that targets the CD4 binding site of the HIV-1 envelope. One variant, VRC07-523, was 5- to 8-fold more potent than VRC01, neutralized 96% of viruses tested, and displayed minimal autoreactivity. To compare its protective efficacy to that of VRC01 in vivo, we performed a series of simian-human immunodeficiency virus (SHIV) challenge experiments in nonhuman primates and calculated the doses of VRC07-523 and VRC01 that provide 50% protection (EC50). VRC07-523 prevented infection in NHPs at a 5-fold lower concentration than VRC01. These results suggest that increased neutralization potency in vitro correlates with improved protection against infection in vivo, documenting the improved functional efficacy of VRC07-523 and its potential clinical relevance for protecting against HIV-1 infection in humans. In the absence of an effective HIV-1 vaccine, alternative strategies are needed to block HIV-1 transmission. Direct administration of HIV-1-neutralizing antibodies may be able to prevent HIV-1 infections in humans. This approach could be especially useful in individuals at high risk for contracting HIV-1 and could be used together with antiretroviral drugs to prevent infection. To optimize the chance of success, such antibodies can be modified to improve their potency, breadth, and in vivo half-life. Here, knowledge of the structure of a potent neutralizing antibody, VRC01, that targets the CD4-binding site of the HIV-1 envelope protein was used to engineer a next-generation antibody with 5- to 8-fold increased potency in vitro. When administered to nonhuman primates, this antibody conferred protection at a 5-fold lower concentration than the original antibody. Our studies demonstrate an important correlation between in vitro assays used to evaluate the therapeutic potential of antibodies and their in vivo effectiveness.

Spinal cord injury models: a review

Animal spinal cord injury (SCI) models have proved invaluable in better understanding the mechanisms involved in traumatic SCI and evaluating the effectiveness of experimental therapeutic interventions. Over the past 25 years, substantial gains have been made in developing consistent, reproducible and reliable animal SCI models. Review. The objective of this review was to consolidate current knowledge on SCI models and introduce newer paradigms that are currently being developed. SCI models are categorized based on the mechanism of injury into contusion, compression, distraction, dislocation, transection or chemical models. Contusion devices inflict a transient, acute injury to the spinal cord using a weight-drop technique, electromagnetic impactor or air pressure. Compression devices compress the cord at specific force and duration to cause SCI. Distraction SCI devices inflict graded injury by controlled stretching of the cord. Mechanical displacement of the vertebrae is utilized to produce dislocation-type SCI. Surgical transection of the cord, partial or complete, is particularly useful in regenerative medicine. Finally, chemically induced SCI replicates select components of the secondary injury cascade. Although rodents remain the most commonly used species and are best suited for preliminary SCI studies, large animal and nonhuman primate experiments better approximate human SCI. All SCI models aim to replicate SCI in humans as closely as possible. Given the recent improvements in commonly used models and development of newer paradigms, much progress is anticipated in the coming years.

A nonparametric method for detecting fixations and saccades using cluster analysis: Removing the need for arbitrary thresholds

Eye tracking is an important component of many human and non-human primate behavioral experiments. As behavioral paradigms have become more complex, including unconstrained viewing of natural images, eye movements measured in these paradigms have become more variable and complex as well. Accordingly, the common practice of using acceleration, dispersion, or velocity thresholds to segment viewing behavior into periods of fixations and saccades may be insufficient. Here we propose a novel algorithm, called Cluster Fix, which uses k-means cluster analysis to take advantage of the qualitative differences between fixations and saccades. The algorithm finds natural divisions in 4 state space parameters-distance, velocity, acceleration, and angular velocity-to separate scan paths into periods of fixations and saccades. The number and size of clusters adjusts to the variability of individual scan paths. Cluster Fix can detect small saccades that were often indistinguishable from noisy fixations. Local analysis of fixations helped determine the transition times between fixations and saccades. Because Cluster Fix detects natural divisions in the data, predefined thresholds are not needed. A major advantage of Cluster Fix is the ability to precisely identify the beginning and end of saccades, which is essential for studying neural activity that is modulated by or time-locked to saccades. Our data suggest that Cluster Fix is more sensitive than threshold-based algorithms but comes at the cost of an increase in computational time.

Procedures for mucosal immunization and analyses of cellular immune response to candidate HIV vaccines in murine and nonhuman primate models.

Sampling the mucosal tissues and analyses of immune responses are integral to vaccine-development strategies against human immunodeficiency virus (HIV), which is transmitted predominantly across the oro-genital mucosa. While immune assay development and standardization attempts employ mouse models, immunogenicity and protective efficacy that can be extrapolated to humans are realized only from experiments in nonhuman primates. Here, we describe commonly used practices for immunizations in rhesus macaques (Macaca mulatta) along with procedures for obtaining important mucosal tissues samples from macaques and mice. We also describe detailed protocols for two important assays applicable in mouse as well as primate experiments for determining antigen-specific T cells responses induced after vaccination.

Neural representations of perceptual and semantic identities of individuals in the anterior ventral inferior temporal cortex of monkeys

AbstractSince the discovery of “face cells” in the early 1980s, single‐cell recording experiments in nonhuman primates have made great contributions toward elucidation of the neural mechanisms underlying face perception and recognition. In this article, I review the recent progress in face cell studies, including recent research into the face patches scattered around the anterior temporal cortical areas of monkeys. In particular, I focused on the neural representations of individual identity in these areas. Several groups have shown that the population of face cells in the anterior ventral inferior temporal cortex of monkeys represents the perceptual identity of faces in a view‐invariant manner. In this context, I also summarized our own study showing that the face‐cell population in the anterior ventral inferior temporal cortex of monkeys, which represents the perceptual identity of the faces, can also represent the semantic identity of the individuals; the learned paired associations between an abstract picture and a particular facial identity were also represented in the anterior ventral IT cortex.

Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines

Correlates of protection (CoPs) against infection by primate lentiviruses remain undefined. Modest protection against HIV-1 was observed in one human vaccine trial, whereas previous trials and vaccine-challenge experiments in non-human primates have yielded inconsistent but intriguing results. Although high levels of neutralizing antibodies are known to protect macaques from mucosal and intravenous viral challenges, antibody or other adaptive immune responses associated with protection might also be mere markers of innate immunity or susceptibility. Specific strategies for augmenting the design of both human trials and animal experiments could help to identify mechanistic correlates of protection and clarify the influences of confounding factors. Robust protection may, however, require the combined actions of immune responses and other host factors, thereby limiting what inferences can be drawn from statistical associations. Here, we discuss how to analyze immune protection against primate lentiviruses, and how host factors could influence both the elicitation and effectiveness of vaccine-induced responses.

‘‘70th Birthday Professor Riederer’’ Induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (−)deprenyl: a way to a disease-modifying therapy?

Neuroprotection has been proposed in neurodegenerative disorders, such as Parkinson's and Alzheimer's diseases, to delay or halt disease progression or reverse neuronal deterioration. The inhibitors of type B monoamine oxidase (MAO), rasagiline and (-)deprenyl, prevent neuronal loss in cellular and animal models of neurodegenerative disorders by intervening in the death signal pathway in mitochondria. In addition, rasagiline and (-)deprenyl increase the expression of anti-apoptotic Bcl-2 protein family and neurotrophic factors. Neurotrophic factors, especially glial cell line-derived neurotrophic factor (GDNF) and brain-derived derived neurotrophic factor (BDNF), are required not only for growth and maintenance of developing neurons, but also for function and plasticity of distinct population of adult neurons. GDNF and BDNF have been reported to reduce Parkinson and Alzheimer's diseases, respectively. GDNF protects the nigra-striatal dopamine neurons in animal models of Parkinson's disease, and its administration has been tried as a disease-modifying therapy for parkinsonian patients. However, the results of clinical trials have not been fully conclusive and more practical ways to enhance GDNF levels in the targeted neurons are essentially required for future clinical application. Rasagiline and (-)deprenyl induced preferentially GDNF and BDNF in cellular and non-human primate experiments, and (-)deprenyl increased BDNF level in the cerebrospinal fluid of parkinsonian patients. In this paper, we review the induction of GDNF and BDNF by these MAO inhibitors as a strategy of neuroprotective therapy. The induction of prosurvival genes is discussed in relation to a possible disease-modifying therapy with MAO inhibitors in neurodegenerative disorders.

Identification of phosphodiesterase 9A as a cyclic guanosine monophosphate–specific phosphodiesterase in germinal vesicle oocytes: a proposed role in the resumption of meiosis

To identify a cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase (PDE) in nonhuman primate germinal vesicle (GV) oocytes and establish a proposed effect on oocyte maturation through preliminary experiments in mouse GV oocytes. Controlled nonhuman primate and rodent experiments. Academic research institution. Rhesus macaques and B6/129F1 mice. Stimulation of Rhesus macaques with follicle-stimulating hormone (FSH) to collect GV oocytes and cumulus for gene expression analysis, and stimulation of female mice with pregnant mare serum gonadotropin to collect GV oocytes. Expression of PDE transcript in primate GV oocytes and cumulus cells, measurement of fluorescence polarization of phosphodiesterase 3A (PDE3A) activity, and analysis of spontaneous resumption of meiosis in mouse GV oocytes. Of five PDE transcripts detected in Rhesus GV oocytes, only PDE9A was cGMP-specific. The fluorescence polarization assays indicated cGMP has an inhibitory effect on PDE3A while the phosphodiesterase 9A (PDE9) inhibitor, BAY73-6691, does not. Similarly, BAY73-6691 had little effect on preventing spontaneous maturation in oocytes, but did augment the inhibitory effects of cGMP. Inclusion of 0 μM (control), 10 μM, 100 μM, and 1 mM BAY73-6691 statistically significantly increased the proportion of mouse oocytes maintaining GV arrest in the presence of the cGMP analog 8-Br-cGMP at 100 μM (8.8%, 11.4%, 18.8%, and 28%), 500 μM (21.1%, 38.1%, 74.5%, and 66.5%), and 1 mM (57.8%, 74.5%, 93.9%, and 94.0%), respectively. Phosphodiesterase 9A (PDE9A) is a cGMP-specific hydrolyzing enzyme present in primate oocytes, and PDE9 antagonists augment the inhibitory effect of cGMP during spontaneous in vitro maturation of GV mouse oocytes.

Quantitative evaluation of the human subventricular zone

ARTICLE Sir, In a recent publication in Brain, van den Berge et al. (2011) examined the brains of 10 controls, 10 patients with Parkinson’s disease, and five cases with incidental Lewy body disease and found no difference in the number of proliferating cells in the subventricular zone, thereby casting doubt on previously obtained evidence suggesting that central dopamine depletion impairs adult neuronal precursor cell proliferation. However, in this recent article the anatomical definition of the region of interest, the sampling procedure, some of the immunostaining procedures and the quantification methods were of limited precision and as such no firm conclusions can be drawn from this study about the dopamine regulation of subventricular zone neurogenesis in the human brain. The subventricular zone around the lateral ventricles in the adult mammalian brain harbours a specialized type of GFAP+ astrocytes, so-called B cells, which act as neural stem cells with the potential to self-renew and to give rise to astrocytes, oligodendrocytes and neurons (Doetsch et al., 1997). B cells generate frequently dividing transit-amplifying C cells. Division of C cells gives rise to A cells, a restricted type of neural precursor cells that can migrate to the olfactory bulb, where they mature into functional interneurons. The potential for neurogenesis is also conserved in the adult human subventricular zone (Sanai et al ., 2004), and as such this population of cells may be a potential resource for endogenous brain repair in brain disorders. To date, a comprehensive series of in vitro and in vivo experiments in adult rodents and non-human primates conducted by various independent research groups has provided compelling evidence that activation of dopamine receptors, mainly D2-type receptors, increases the proliferation of neural precursor cells, mainly C cells, in the subventricular zone (Baker et al., 2004; Coronas et al ., 2004; …

Cortical representations of pitch: theories and experiments

Pitch perception is one of the most important auditory perceptual phenomena. Its underlying neural mechanisms have not been well understood. Recent human imaging studies and neurophysiology experiments in non-human primate have begun to reveal possible neural coding mechanisms in the cerebral cortex. These studies have pointed to a specialized area in the rostral region of primate auditory cortex where harmonic pitch is extracted. How pitch-selective neurons in this cortical area extract harmonic pitch at the cellular level, however, is yet known. Moreover, it remained to be explored whether other auditory cortical areas process aspects of pitch that are not processed by this rostral pitch-region. An important issue in the study of cortical representations of pitch is whether pitch embedded in harmonic complex sounds is extracted and uniquely represented by a specific cortical area or a subset of neurons in that area. Simply showing that pitch information exists in neural firing in a cortical area is not an adequate demonstration of pitch processing mechanisms. (Research supported by NIH grant R01-DC003180)

Early Visual Evoked Potentials: An Indicator of Bioelectrical Activity of the Lateral Geniculate Nucleus?

In non-human primate experiments Schroeder et al. (1992) demonstrated that visual evoked activity of the lateral geniculate nucleus (LGN) can be recorded on the frontolateral epidural surface of macaque monkeys. So far it is not known whether analogous visual evoked potentials can be found on the scalp surface of humans. The search for early visual evoked responses was performed in healthy volunteers with the following technique: white Ganzfeld-flash stimulation (< 100 µsec, 0.81 cd/m2s, frequency 1.1 Hz), low frequency filter 1 Hz, high frequency filter 100 Hz (12 db/octave), averaging of 100 stimulations. A topographic map of responses was recorded at standard electroencephalography scalp positions. In addition to these methods the following parameters were modified: stimulation (flash versus checkerboard reversal, monocular versus binocular), recording of right and left hemisphere responses, frequency filtering and frequency analysis. Scalp mapping of VEP responses indicated an early reproducible response with a wide frontolateral distribution consisting of a small positive and a larger negative potential (= GER - presumed geniculatum evoked response). A closer analysis of responses was performed at 6 different standard electroencephalography scalp positions electrode positions (F2, F4, FC2, FC4, FC6, C4) in 7 healthy volunteers. At FC4 the amplitude of the GER was maximal (4.8 ± 2.9 µV). The peak latencies were: positive wave 31.8 ± 2.8 msec, negative wave 43.6 ± 2.3 msec. Monocular stimulation resulted in nearly identical responses on both hemispheres. Amplitudes increase at binocular stimulation by + 44 % compared to monocular flashes. Frequency filtering and spectrum analysis clearly demonstrate that the GER mainly consists of < 30 Hz components. A comparable response with checkerboard reversal could not be detected after averaging of 100 stimulations and a rudimentary GER was found after 5000 sweeps. An early wide spread visually evoked potential could be identified in humans that seems to be identical to the surface recorded response of the LGN that was previously described in non-human primate experiments.

Unique and shared roles of the posterior parietal and dorsolateral prefrontal cortex in cognitive functions

The dorsolateral prefrontal cortex (PFC) and posterior parietal cortex (PPC) are two parts of a broader brain network involved in the control of cognitive functions such as working-memory, spatial attention, and decision-making. The two areas share many functional properties and exhibit similar patterns of activation during the execution of mental operations. However, neurophysiological experiments in non-human primates have also documented subtle differences, revealing functional specialization within the fronto-parietal network. These differences include the ability of the PFC to influence memory performance, attention allocation, and motor responses to a greater extent, and to resist interference by distracting stimuli. In recent years, distinct cellular and anatomical differences have been identified, offering insights into how functional specialization is achieved. This article reviews the common functions and functional differences between the PFC and PPC, and their underlying mechanisms.